Have Ingevity, Corp. insiders bought shares recently?

No open-market purchase by an insider of Ingevity, Corp. was filed in the last 90 days. The latest on record was on Mar 12, 2020.

How often do Ingevity, Corp. insiders buy and sell shares?

Since 2017, Ingevity, Corp. insiders reported 12 open-market purchases and 17 sales on Forms 4 and 5, with purchases in 2 different years, most recently 2020.

Who is selling Ingevity, Corp. stock?

No open-market sale by an insider of Ingevity, Corp. (NGVT) was filed with the SEC in the last 90 days.

Do members of Congress trade NGVT?

No trade in Ingevity, Corp. (NGVT) was disclosed by a member of Congress in the last 12 months.

Where does this data come from?

From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.

Ingevity, Corp. (NGVT) insider trading and stock trades

Q: When does Ingevity, Corp. report its next results?

Ingevity, Corp.'s next results are expected on Feb 23, 2027, after the market closes. The date can move until the company confirms it. Insiders often trade in the weeks right after results.

OQRO

Ask OQRO about this page

Ask

Want the short version?

Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.

Explain this page What did insiders at NGVT buy and sell in the last 90 days?Which members of Congress and which funds traded NGVT recently?

Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.

NGVT price and disclosed activity

+22.1% (+$11.19) from Nov 13, 2025 to Nov 13, 2026 · adjusted daily closes

13F holdings, by quarter end

Insider and Congress marks sit on the trade date stated in the filing; solid is a purchase, hollow a sale. A number means several trades too close to tell apart at this range: pick a shorter range or open it for the list. Fund 13F reports are quarter-end snapshots filed up to 45 days later, so they are shown under the chart across the quarter they describe, not on the price line. Congress amounts are official ranges; mark size uses the lower bound. Past moves are not a forecast.

Insider open-market trades, filed in the last 90 daysNoneNo open-market trades reportedInsider trades →Congress trades, disclosed in the last 90 daysNoneNo House or Senate report names this stockCongress →Fund 13F changes, quarter ending Jun 30, 20262 added · 2 cut4 followed funds; holdings as of the quarter end, filed by Aug 14, 2026Fund moves →Federal contracts starting in the last 12 monthsNoneNo award found for this companyContracts →

Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.

Specialty Chemicals company based in North Charleston, South Carolina.

Last 12 months

+22.1%

S&P 500 +12.3% over the same dates

Market value

$2.08B

Close of Nov 13, 2026 × shares outstanding (per ADS where it applies)

S&P 500 +12.3% over the same dates. Prices adjusted for splits and dividends.

Short interest: 1.25M shares sold short (3.7% of shares outstanding), −8.2% vs the previous count, 4.4 days of normal trading to buy them back. FINRA, as of Oct 30, 2026.

The last year in context

Trading desk

Against the S&P 500 over the year

NGVT +24.6%S&P 500 fund (SPY) +10.4%

Since Nov 11, 2025, NGVT is up 24.6% and the index fund is up 10.4%: 14 points ahead of the market. Traders call a stock that beats the index over a period a relative-strength leader.

How much NGVT moves

A usual day: ±1.4%Half of the sessions moved less than this, half moved more.
Daily range (ATR 14): 5.2%Average distance between the low and the high of a session, over the last 14.
Largest one-day fall: −13.6%Nov 5, 2026
Largest one-day rise: +5.0%Mar 23, 2026
Deepest fall of the year: −22.8%From the close of May 6, 2026 to Nov 6, 2026.
Days of 5% or more: 4Out of 252 sessions, in either direction.

End-of-day prices. These figures describe the past year and say nothing about what comes next.

Latest results: quarter ending Sep 30, 2026

Revenue

$305M

−8.4% vs the same quarter a year earlier

Free cash flow, last 12 months

$123M

This quarter $85.5M, a year earlier $118M

Net debt

$1.06B

Debt $1.15B, cash $85.4M, at Sep 30, 2026

Net income, last 12 months

$59.8M

From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Nov 4, 2026.

Insider buying and selling since 2017

Insiders of Ingevity, Corp. reported 12 open-market purchases and 17 sales since 2017; purchases in 2 different years, most recently 2020.

Year	Bought	Sold
2023	—	$1.25M6×6 trades
2022	—	$194K2×2 trades
2021	—	$1.08M3×3 trades
2020	$1.4M11×11 trades	$12K1×1 trade
2019	—	$2.88M5×5 trades
2017	$88K1×1 trade	—

Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.

When insiders usually buy

Last results

Nov 4, 2026

Within the 30 days after it, until Dec 4, 2026

Next results, expected

Feb 23, 2027

after the market closes; the date can move until the company confirms it

Purchases after results

67%

8 of 12 insider purchases since 2016 came within 30 days after a results announcement

From Ingevity, Corp.'s own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know Ingevity, Corp.'s policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.

Company size

10-K filed Feb 26, 2026

Revenue, fiscal 2025

$1.17B

−2.7% vs the year before

Net income, fiscal 2025

−$167M

A loss for the year

Shares outstanding

33.8M

As of Nov 3, 2026

In fiscal 2025 the company spent $56.3M buying back its own shares. Cash actually paid, from its cash-flow statement.

Red flags in its filings

Dec 8
Top officer leaving
“Performance Chemicals Leadership Transition Also on December 8, 2025, the Company announced that Richard White, Senior Vice President and President, Performance Chemicals, will depart the Company on May 1, 2026.”
8-K on sec.gov

From the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.

H-1B filings

Department of Labor

0 certified in FY2026 Q3, vs 1 a year earlier.

Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.

Latest

See everything

Fund moves

940KShares reported · +57K vs prior quarter

Filed 3mo ago

4 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.

More Official record

Fund moves

Want the short version?

Ingevity, Corp.

How this filing works

Questions about Ingevity, Corp. insider trading

NGVT price and disclosed activity

The last year in context

Latest results: quarter ending Sep 30, 2026

Insider buying and selling since 2017

When insiders usually buy

Company size

Red flags in its filings

H-1B filings

Latest

940KShares reported · +57K vs prior quarter

21KShares reported · +3,433 vs prior quarter

86KPrior-quarter shares · no longer reported

1.05MShares reported · -54K vs prior quarter

1.11MShares reported · -109K vs prior quarter

Other Specialty Chemicals companies

H-1B filings

The last year in context

When insiders usually buy

Insider buying and selling since 2017

Red flags in its filings